Pioglitazone-d4

• CAT Number: R065751
• CAS Number: 1134163-29-3
• Molecular Formula: C19H20N2O3S
• Molecular Weight: 360.464
• Purity: ≥95%
• Synonyms: 5-​[[4-​[2-​(5-​ethyl-​2-​pyridinyl)​ethoxy]​phenyl-​2,​3,​5,​6-​d4]​methyl]​-2,​4-​thiazolidinedione
• Target: Vitamin D Related/Nuclear Receptor
• Storage: -20°C
• Related CAS: 111025-46-8 (unlabelled)
• IUPAC Name: 5-[[2,3,5,6-tetradeuterio-4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
• InChI: InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)/i4D,5D,7D,8D
• InChIKey: HYAFETHFCAUJAY-YBNXMSKUSA-N
• SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3

Pioglitazone-d4 is a deuterated form of the antidiabetic drug pioglitazone, containing four deuterium atoms for enhanced stability and precision in research. This isotopically labeled compound is crucial for studying the pharmacokinetics, metabolism, and therapeutic effects of pioglitazone in treating type 2 diabetes. Pioglitazone-d4 ensures reliable and consistent results in advanced pharmaceutical research and clinical studies, making it an essential tool for scientists and healthcare professionals developing new diabetes treatments. Ideal for use in mass spectrometry and other analytical techniques, it supports accurate tracking in biological systems.